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A sequential analysis ofUveralJogrtfft rejection In 
seuUb:ed rats using i""""nopatbologlcal and ul· 
trast"'ctural microscopy Is described. Lewis rats 
were primed wUb four ACI silin grafts and cbal· 
Ienged wUb an arterialized ACI ortbotoplc liver 
alIDgraft 14 to 17 wee.s later. The seultb:atlon 
resulted In a mix of IgG and IgM lympbocytotoxu: 
antibodies at a tUer of 1:512 at tbe time oftrau· 
plantatiofL Specljfdty analysis of pretrauplant 
I"""une sera revealed a predominance of IgG 
anti-class I major blstocompatlbUIty complex 
(RTl) antibodies wUb a minor IgGfractlon sbow· 
Ing apparent endothelial ceU specljfdty (non· 
RTl). This IefJeI of seuUb:atlon was associated 
wUb accelerated grtfftfau"re In 3 to 5 daysfrom 
mixed bumoral and celbllar rejectlofL Sequential 
analysis of serial posttrauplant grtfft biopsies 
revealed dl.f/'u$e v"",,lar IgG uposUlon and 
platelet tbromblln portal velu and periportal sl· 
nusolds witbln 3 """"s after reperfuslofL This 
wasfoUowed by endothelial ceU bypertropby and 
vacuolb:atlon. periportal hepatocyte necrosis, 
arterial spasm,focallarge bile duel necrosis, and 
bllar mast ceU inj'Utratlon and degranulatlofL 
However. Ibe liver allDgrafts did notfaU precip-
Itously and byperacute rejection was nOl seen. 
KupUer ceU pbagocytosis oftbe sinusoidal plate-
lets began as early as 30 mI""'es posttrauplant 
and by 24 bours, tbe platelet tbrombl bad de-
creased. CboIaIIgIoIes appeared focally at tbe 
edge of the U,.,.. p~s by 2 to 3 days, appar-
ently In resporue to earlier periportal bepatocyte 
damage. A mono""c1ear portal and perivenular 
Injfllrate became evident at 3 days, and graftfaU-
ure was attributed to botb antibody and cell-
mediated rejection (Pu",ya el al: Preformed lym-
pbocytotoxlc antibodies: Hepatology 1992, 16: 
1415-1422). The model described resembles 
observatlou In erossmatcb positive buman liver 
alIDgrtfft reciPient&. The mecbanisms of bepatlc 
grtfft resistance to antibody mediated rejection 
and tbe possible long term couequences of early 
damage to tbe biliary tree are discussed. (Am} 
Patboll993. 142:1383-1391) 
We have recently described a characteristic graft 
syndrome in patients harboring preformed Iympho-
cytotoxic antibOdies (LAbs). which included in-
creased intraoperative use of blood products. lower 
postoperative platelet counts. poorer early posttrans-
plant graft function. and an increased incidence of 
rejection and graft failure. 1-3 However. hyperacute re-
jection was rarely seen. The livers showed a variety of 
pathological changes. including findings similar to 
preservation injury. cellular rejection. arterial vaso-
spasm. and focal large bile duct necrosis.3 Although 
the changes were attributed to antibody (Ab)medi-
ated attack. only focal deposits of IgG and comple-
ment could be detected in the failed grafts.3 It was 
conceivable. but unlikely. that nonimmunological 
complications could have led to a similar. if not iden-
tical pathology.:3 
We began studies in rats to elucidate the patho-
physiological interactions between preformed LAbs 
and liver allografts. In the first.series of experiments. 
we noted a direct correlation between LAb titer and 
graft survival and identified IgG Abs as the most de-
structive.4 In this study. our goal was to investigate the 
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Absorption Studies 
Specificity of the preformed Iymphocytotoxic Abs 
was further investigated by absorption of the Im-
mune sera with ACI red blood cells (RBCs), which 
are known to carry surface class I major histocom-
patibility complex (MHC, RT1) antigenic determi-
nants. Briefly, 1.0 cc packed ACI RBCs was mixed 
with 0.5 ml of pooled pretransplant ACI-immune 
LEW sera at room temperature for 30 minutes and 
then centrifuged for 10 minutes at 2,000 RPM. LEW 
RBCs were used as a control. The procedure was 
repeated twice. The rema.ining supernatant was col-
lected and tested for Iymphocytotoxic activity and 
binding to normal ACI liver tissue sections by indi-
rect IF (see above). 
Electron Microscopy 
Tissue samples were Immersed in Karnovsl<y's fixa-
tive containing 2% paraformaldehyde and 2.5% gl-
utaraldehyde in 0.2 mol/L cacodylate buffer With 
0.01% calcium chloride at pH 74 Samples were 
dehydrated in ethanol and embedded in epon-
araldite after propylene OXide/resin infiltration. Spec-
imens were vacuum Infiltrated and polymerized at 
60 C overnight. Thin sections were cut on a Sorval 
MP5000 and collected on water. Sections in the 
pale gold to silver interference spectra were then 
poststained in alcoholic uranyl acetate and Rey-
nold's lead citrate. Thin sections were viewed on a 
CM12 Phillips microscope at an accelerating volt-
age of 60 kv and photographed at a final magnifica-
tion of x3,000 to x 24,000. 
Results 
Characterization of Pretransplant Immune 
Sera 
Pooled immune sera obtained immediately before 
transplantation from sensitized LEW recipients was 
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cytotoxic to unfractionated ACI lymphocytes at a ti-
ter of 1 :29 . Absorption of the sera with ACI RBCs al-
most completely depleted the Iymphocytotoxic ac-
tivity (1 :2'), in contrast to absorption with LEW 
RBCs. which only slightly lowered the titer (1 :26 ), 
likely because of a dilutional effect. 
Indirect IF analysis of non absorbed pretransplant 
immune sera at room temperature revealed diffuse 
IgG » IgM portal and central veins, sinusoidal, he-
patic arterial, hilar capillary endothelial, and bile 
duct cell reactivity. When the assay was performed 
at 37 C, IgM binding decreased, whereas IgG bind-
ing increased slightly. Immune sera absorbed with 
ACI RBCs continued to show strong capillary and 
larger vessel endothelial IgG reactivity. whereas si-
nusoidal binding decreased substantially, and bile 
duct cell staining was not seen. The results are 
summarized in Table 1. 
Graft Survival and Correlation with 
Antibody Class, Titer. and Specificity 
We have previously shown that liver allograft sur-
vival after four senSitizing skin grafts In the ACI to 
LEW model is directly proportional to antibody titer, 
class, and specificity.4 In those experiments,4 it was 
shown that preformed IgG Iymphocytotoxic antibod-
ies accelerated graft failure. If the liver grafts were 
placed S 12 weeks after skin sensitization (X 4), hy-
peracute or pure humoral rejection was seen. If 
however, the liver grafts were transplanted between 
12 to 16 weeks after senSitization, graft survival was 
less than unsensitized controls, and graft failure 
was attributable to a combination of antibody and 
cell·mediated rejection.4 
The experiments described below were con-
ducted to determine the sequence of rejection in 
sensitized recipients, who do not hyperacutely re-
ject but experience accelerated graft injury and fail-
ure. The model closely mimiCS the clinical. situation 
in patients with a pOSitive crossmatch.3 
Table 1. The Effect of AbsorptIon and Tempemture on Inlrahl!{Xllic BindinR 0/ Pretransplalll Immlwe ~I>ra 
Immunofluorescen1 staining (20 C/37 C) 
Sera Crossmatch titer Vascular endothelium· Biliary epithelium Sinusolds 
Pretransplant 1:~ IgG +++/+++ +++/+++ ++/++ 
IgM +/- +/- ++/+ 
After absorption With LEW RBCs 1:~ IgG ++/++ ++/++ +/++ 
IgM +1+ -/- ++/+ 
After absorption With ACI RBCs 1:2' IgG ++/++ 
-1- -1-
IgM +/+ -1- -1-
• HeoatlC artery. portal ana central vein. ana nllar capillary enaotnellum. 
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Table 2. PatboloRical Course 0/ Sensitized LiL'f!r AIIORraJt aJter Rf!l'asclliarizatioll 
Postrevascularization periods 
1-3 minutes 10-30 minutes 1-3 hours 6-24 hours 36-48 hours 72-96 hours 
Platelet plugging + 
Endothelial hypertrophy/vacuolization 
Hepatocyte necrosIs 
SinuSOidal neutrophilia 
Neutrophilic portal venulitis 
Portal artery thickening 
Arterial myocyte vacuolization 
Cholanglolar proliferation (focal) 
Mononuclear inflammatory infiltrate 
Biliary sludge 
IgG 
Sinusoids + 
Portal and central veins + 
Figure 2. pfflD/~fffo oj' plal£'I,'I,' mllM he del,'CI,'" III lile portal "'m.. 
,/lid PI."rlport(/1 .<llII/,.md. /I'IIMII / 10 .I ""''''I,'S alier rDDmf!~/i/K<ioll / he-
/lllIlunllll a,ul ,nm, 111(,1:1. X ~E>egI 
denudation. mild focal pen portal sinusoidal. and in-
travenular sludging of neutrophils and fibrin could 
be seen, However. the neutrophil sludglng was not 
particularly stnking. as IS seen With humoral relec-
tlon of kidney or heart allografts. 
Between 6 to 12 hours. muscular arteries in the 
hilum showed medial thickening and more pro-
Figure 3, ,1/"rWrJ .... "pemalllL.Cl.OSlSal()hm/l.Saflerr.l.lYISCllla"za. 
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Figure 4. (,1}(1II1I.t!S .</IRI/('SI/I'(' "lllrtt!"nl,<{JLISIII. $/I('b a.< lIIediallbick, 
'·IIillll.. u'""k/illll. "llhe 1III"rl/tll "llI$II<'a 1"'"11114, lIIe",alllllO"yl£, I'ac-
lIo/izal",", lI11d ""doll,,·/i,,1 hlpt.'rtNlI'/!I· '''','/I/TI.'(/ III II", ""nh/lar h", 
1>t,/iC lIrten,'S Ik'IIn"'II () "",I I.! ''''/lrs 1",<lIrt1l1.<"ltllll f pl,w,,, 
('",/wt/C/(-,j Ih,ek S,'C.:/WII jilr ('/(''('In,,, IlIIl.,.CJ.."cu/"· twt/"/"If! hitit': 
X 7('HJ .\'u/(,lIlso the ('t,r/\'I1I/iltrtllll", o{lI1a."il ('('// ... ("mm'h('cuL", '''u/ 
1,/all1ft" IIIl1n.t'"cIfIfJII tlltf"K~ Ih" (,urt,II ,...'11' ('''""UI'J. 
nounced wrinkling of the Internal elastic lamina. 
suggestive of artenal spasm (Figure 4), The con-
gestion In the pen biliary vascular plexus increased. 
and collarettes of partially degranulated mast cells 
rimmed the artenes. Mast cells also appeared in-
creased in the connective tissue around large hilar 
bile ducts (Figure 4). 
Small infarcts developed in the hepatiC paren-
chyma and periductal connective tissue and focally 
involved the walls of hilar excretory bile ducts by 12 
hours (Figure 5). Although neutrophlls were present. 
they were not conspicuous. except In the case of in-
farction. 
Small intralobular and larger septal bile duct cells 
showed an increased nuclear:cytoplasmlc ratio be-
tween 24 to 36 hours. and cholangloles appeared 
focally at the edge of the limiting plate by 72 hours. 
marked by the appearance of focal infarcts, Be-
cause of these similarities. we feel this represents a 
reasonable model to explain some of the histo-
pathological findings In humans and to study the 
role of other donor or recipient co-factors. which 
may influence graft survival in crossmatch-positive 
patients, 
The hypersensitized system reported by Knechtle 
et al" was Important to show that liver allografts 
were susceptible to damage from P!eformed Iym-
phocytotoxlc Abs but lack of arterial reconstruction. 
and the rapidity and mode of graft failure was 
largely Inconsistent with clinical observations, 1 J 
Studies by Gubernatls et al '2 in primates were more 
akin to clinical observations. but limitations are Im-
posed by the use of large animals, Other models of 
liver relectlon In sensitized small animal recipients 
have emphasized hepatic resistance to preformed 
Abs. 131 t> although a deleteriOUs effect on graft sur-
vival was observed, 13-15 
An allograft liver placed Into a sensitized recipI-
ent may begin to hyperacutely relect. like kidney or 
heart allograf1s, If the preformed allo-Abs are of 
-----------~""~--.. ,.,-.. -.-,., .. "'-.. ,,--,--.--------
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Figure 8. A: {llrtlslnlCllIl'(' (ltlll'('r In IIllllll/t'.'· a/ier ortenal aflasll~ 
I1IOSIS: Ib(' entire sUlIls(lui IS lilll'ciIl'I,h "Ia/eft·/ lind platelet (ra,Q,meuls. 
occaswluli n~1 o!lIs tlllci /ihnll. /11(' slImJllltliuJ,1!, /le{Jalo(:r/('s (II) tiff! 
rdulll'f.41' lIlIremark"hl" C'.\'(:t'!JI.lCJr O(:caSlUllllJ /11(('111 rauwlt's wllhu, 
'he c\·toplaslll All ad;act'llf K//{II)i'r (<,1/ sho//'s s//tll/lIr /'(/c/wilzallo" 
//lId 1/" f!I'"If!IICe o/pla/ele/ pb(/,lll)(''l'/n'l' / Ilrtlll.\'1 (Kf!/(I/e (lIId lead c.' 
Irate. mtlKDlKff~/icK:tltwlf = x '1, ;'O()J. B: "Vier .1 hUIITS. Ihe .'o:tllltsoidti are 
sJiIl sll'ollell. c:uIIIUIIIIII.1l IIlItlCI allti lit/,llm('"(,,c/ plll/(l/eIS, l/ou'f!l.'f!r. 
KllpJJi!r cell.> wlI/allllllg jre/RII/ell'.> ul,,/(/I,'I,'I.>, ClllI ,m,,' hr.- df!I,'CIf!d, 
III addili(lll, IIl1l1/emll.> _',"''<II"lm,' /1','"'''''''''' liIIlb,' KllfJ))i!r cell n'/()-
plasm, (/I.d (I,:caslOlIlIl I'"eI c('11 /mR""'II''> ",.,... ,'<'1.'11. 1/,'pa/ocvt('S 
s/)ou' ill,'rly/sed IIl1mhtJ ,-s 0/ "/11£1 drop/(lts I,,,d fH.Xlll'Wllal L'ClC1WIf!S 
/IIYUII,IY (/,'(,/,11" "IItI I,,(/d Cllrtl/", 1f/"I~l/flic"frgff = x -I. -:'001, C: Alier 
14 bOllTS, Ih(' SlIlIt.WIlc/S were tI!'If"'" (IIIti (.""<.'11""'11,1.( reel (.'("'s (II "dell', 
Kllpp}i!r cells IWII' om/all' II"IIl('rOIl." l'b(I .... 'u. .. umtlS .. wllle u'bi,'b hUl'f! 
plaleie/ Rre/III1/''S (/11<1 j'(/gll/"I/f.>. '/1"'1'1"'> (',\11tIl/,""" u/ the ,'pace oI 
/)i.'tI!, (111£1 hepalc}(:vlt', .. "(Jllttl'" srmwlI'htit "",r('(l,\'ecl ffflnhEgD~i v/ {\'SOS-
owes (IlTillll'l acettl/t' "lid /"tt" (.'Ilra/l'. lff{lK~"I/iulllrll = x -I. 7(0). 
high liter. IgG class and show endothelial binding. 
rapid graft failure may ensue~ However, If the allo-
Abs are of lower titer or IgM class or show less 
endothelial speclficityI~ we have shown that the liver 
is often able to Withstand the Initial damage. adapt-
ing and responding to the injury, In humans. Iym-
phocytotoxlc Abs are usually of relatively low titer 
and are only occaSionally detected in titers> 1 :512. 
which may at least partially account for the rarity of 
hyperacute relectlon In clinical liver transplantation, 
The Immune sera produced by the skin senSitiza-
tion protocol contained a mix of IgG and IgM antl-
bodies~ With a predominant speCifiCity for anti-class 
I MHC (An) antigens and a lesser component, ap-
parently speCific for endothelial cells, ThiS conclu-
sion IS based on absorption of Iympnocytotoxlc ac-
tivity by ACI ABCs but continued presence of antl-
endothelial IgG Abs by Indirect IF despite 
absorption, Further studies are currently underway 
to characterize more preCisely the speCificities and 
to determine which Ab IS the more destructive In 
passive administration assays, Not unexpectedly. 
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